Medtronic Eyes New Product Stream
Medical-device maker Medtronic Inc. expects to release 60 "major" products during the fiscal year that runs through next April and isn't eying large-scale acquisitions, the company's chairman said Monday. online.wsj.com |
VIVUS Inc. Q2 2010 Earnings Call Transcript
VIVUS Inc. (VVUS)Q2 2010 Earnings Call TranscriptAugust 2, 2010 4:30 pm ETComplete Story » seekingalpha.com |
Stem Cell Confusion Creates Opportunity in These Four Names
Zacks.com submits: By Jason Napodano, CFA On Monday, August 23, 2010, the Federal District Court for the District of Columbia issued a temporary injunction on President Obama’s 2009 executive order that expanded federal funding for embryonic stem cell research, returning to order the previous ban enforced by the Bush administration in 2001. The news immediately halts National Institutes of Health (NIH) funding at academic and private research labs on embryonic stem cells. The ruling was a surprise, as several research programs had already initiated work under President Obama’s executive order.Complete Story » seekingalpha.com |
Oseltamivir Improves Survival - Video
New Study Indicates That Even Delayed Treatment With Oseltamivir Improves Survival in Patients Infected With Avian Influenza (H5N1) feedproxy.google.com |
Amarin Has All the Makings of an Attractive Acquisition Target
M.E. Garza submits: By Patrick CrutcherAmarin (AMRN) announced very positive results from their Phase 3 MARINE trial with AMR-101. The drug was effective in reducing triglycerides and was LDL-C neutral. We see them as an attractive takeover target going into 2011.Complete Story » seekingalpha.com |